Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Average Target - GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price - GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

f566d7b79d2.Srisj-GQaJNIZ22VG8p6T4LEB3ciQPNVvW-hNRZW2HQ.O93IvoXTDPY6IQLbfJkABfCsfxhKdLAhyznvU0N7r0Bz1OrriOc64gwRAg~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
Average
Weighted average by Cap.


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
312.45PKR
Average target price
510.00PKR
Spread / Average Target
+63.23%
High Price Target
510.00PKR
Spread / Highest target
+63.23%
Low Price Target
510.00PKR
Spread / Lowest Target
+63.23%

Analyst Consensus Detail

Analyst consensus - GlaxoSmithKline Pakistan Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - GlaxoSmithKline Pakistan Limited
  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited